Uptake of new cancer medicines still differs more than three-fold between European countries, though the gap has narrowed ...

Governor Josh Shapiro and Department of Community and Economic Development (DCED) Secretary Rick Siger announced the ...

New US cancer indications and an antiviral approval featured among human medicines regulatory updates from October 6 to 12, ...

ANI Pharmaceuticals today announced that both 6-month and 24-month data from SYNCHRONICITY, its Phase IV, open-label, ...

US biotech City Therapeutics is seeking about $175 million in an initial public offering (IPO) to support three experimental ...

The US Food and Drug Administration (FDA) has signaled a clear shift in how it intends to scrutinize clinical trial data ...

US biotech company Revolution Medicines (Nasdaq: RVMD) faces fresh questions about how its pancreatic cancer treatment ...

Concept Life Sciences, specializing in integrated drug discovery, development and analytical services, today announced the ...

The Food and Drug Administration (FDA) has approved Hovilpri (pritelivir) 100mg tablets for the treatment of mucocutaneous ...

Belgian pharma trade group pharma.be welcomes the new Belgian Cancer Plan 2026-2036. The innovative biopharmaceutical sector ...

Chai Discovery, the San Francisco-based AI company building computer-aided design tools for molecules, has announced a ...

September 2026 brought a series of important advances in rare disease treatment, with several therapies receiving their first ...